The Cancer Prevention and Control (CPC) Program of The Tisch Cancer Institute (TCI) is comprised of members who share a common goal to reduce the burden of cancer incidence and mortality and improve the lives of cancer patients, with emphasis on the population in the community the TCI serves. Collaboratively, they study cancer risk factors, early detection and screening and healthcare delivery.
The Program aims to evaluate and mitigate cancer risk factors with special attention to those most prevalent in the TCI community, to develop effective early detection and screening strategies for groups at higher risk while addressing health disparities, and to improve the quality of care and quality of life of people affected by cancer through healthcare delivery.
Projects within CPC are developed along the cancer continuum from primary prevention to early diagnosis, treatment, and follow-up. Projects are designed by the integration of expertise across disciplines, including clinical sciences, molecular biology and genetics, epidemiology, health services research, and health psychology. Disparities in cancer risks and outcomes are addressed in special populations, such as ethnic minorities and individuals exposed to the World Trade Center attack and its aftermath, which can experience a disproportionate burden of cancer. Major CPC research projects are based on multi-institution consortia collaborations, both nationally and internationally, in which CPC members play a key coordinating role.
Scientific Themes:
- Risk Factor Evaluation and Mitigation
- Cancer Early Detection and Screening
- Healthcare Delivery
